News

Filter

Current filters:

GenVec

Another milestone for GenVec in hearing and balance collaboration

13-02-2014

US biotech firm GenVec says it has achieved the third milestone in its collaboration with Swiss drug…

BiotechnologyCGF166FinancialGenVecLicensingNeurologicalNovartis

GenVec extends research deal with Novartis

29-01-2012

US biopharma company GenVec (Nasdaq: GNVC) says that it has extended its research collaboration and license…

BiotechnologyGenVecNeurologicalNovartisPharmaceuticalResearch

Novartis in licensing deal with Cellectis; pays milestone to GenVec

07-12-2011

Paris, France-based Cellectis genome engineering specialist (Alternext: ALCLS) has signed a license agreement…

BiotechnologyCellectisGenVecLicensingNeurologicalNovartisPharmaceutical

GenVec signs new deal with Novartis on hearing disorder clinical trial material

09-08-2010

USA-based GenVec saw its share price rise 12% to $0.57 in pre-market trading last Friday, after the company…

GenVecLicensingNeurologicalNovartisPharmaceutical

GenVec presents encouraging data from malaria vaccine study

13-04-2010

In an announcement that has been widely anticipated, Maryland, USA-based biotechnology firm GenVec presented…

BiotechnologyGenVecPharmaceuticalResearchTropical diseasesVaccines

GenVec nose-dives as it halts pancreatic cancer drug trial on poor results

31-03-2010

Another once-promising cancer drug hit the buffers, when USA-based GenVec revealed that, after advice…

GenVecOncologyPharmaceuticalResearchTNFerade

Back to top